HPCM
ABBV icon

Hunter Perkins Capital Management’s AbbVie ABBV Stock Holding History

Hunter Perkins Capital Management’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-15,050
Closed -$1.61M – 85
2020
Q4 		$1.61M Buy
+15,050
New +$1.45M 0.29% 61

Other funds holding ABBV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Berkshire Hathaway
Berkshire Hathaway Omaha, Nebraska $263B AUM 16.68% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Hunter Perkins Capital Management's ABBV Position: Q1 2021 in Review

Hunter Perkins Capital Management sold out of AbbVie (ABBV) in Q1 2021, closing a stake of 15,050 shares — an estimated $1.61M sold.

Hunter Perkins Capital Management first reported a position in ABBV in Q4 2020 and held it in 1 quarter. The position peaked at $1.61M in Q4 2020. 2,615 funds tracked by Wall St. Rank hold ABBV as of Q1 2021.

  • Hunter Perkins Capital Management reported no remaining AbbVie position as of Q1 2021 after selling out during the quarter.
  • Hunter Perkins Capital Management sold 15,050 AbbVie shares in Q1 2021, an estimated $1.61M.
  • Hunter Perkins Capital Management first reported a position in AbbVie in Q4 2020 and held it in 1 quarter.
  • Hunter Perkins Capital Management's AbbVie position peaked at $1.61M in Q4 2020.
  • 2,615 funds tracked by Wall St. Rank held AbbVie as of Q1 2021.

Based on Hunter Perkins Capital Management's 13F filing for Q1 2021, filed 28 Apr 2021.